The UAE healthy future study

a pilot for a prospective cohort study of 20,000 United Arab Emirates nationals

Abdishakur Abdulle, Abdullah Alnaeemi, Abdullah Aljunaibi, Abdulrahman Al Ali, Khaled Al Saedi, Eiman Al Zaabi, Naima Oumeziane, Marina Al Bastaki, Mohammed Al-Houqani, Fatma Al Maskari, Ayesha Al Dhaheri, Syed M. Shah, Tom Loney, Mohamed El-Sadig, Abderrahim Oulhaj, Leila Abdel Wareth, Wael Al Mahmeed, Habiba Alsafar, Benjamin Hirsch, Fatme Al Anouti & 18 others Jamila Yaaqoub, Claire K. Inman, Aisha Al Hamiz, Ayesha Al Hosani, Muna Haji, Teeb Alsharid, Thekra Al Zaabi, Fatima Al Maisary, Divya Galani, Tim Sprosen, Omar El Shahawy, Jiyoung Ahn, Tomas Kirchhoff, Ravichandran Ramasamy, Ann Marie Schmidt, Richard Hayes, Scott Sherman, Raghib Ali

Research output: Contribution to journalArticle

Abstract

BACKGROUND: The United Arab Emirates (UAE) is faced with a rapidly increasing burden of non-communicable diseases including obesity, diabetes, and cardiovascular disease. The UAE Healthy Future study is a prospective cohort designed to identify associations between risk factors and these diseases amongst Emiratis. The study will enroll 20,000 UAE nationals aged ≥18 years. Environmental and genetic risk factors will be characterized and participants will be followed for future disease events. As this was the first time a prospective cohort study was being planned in the UAE, a pilot study was conducted in 2015 with the primary aim of establishing the feasibility of conducting the study. Other objectives were to evaluate the implementation of the main study protocols, and to build adequate capacity to conduct advanced clinical laboratory analyses.

METHODS: Seven hundred sixty nine UAE nationals aged ≥18 years were invited to participate voluntarily in the pilot study. Participants signed an informed consent, completed a detailed questionnaire, provided random blood, urine, and mouthwash samples and were assessed for a series of clinical measures. All specimens were transported to the New York University Abu Dhabi laboratories where samples were processed and analyzed for routine chemistry and hematology. Plasma, serum, and a small whole blood sample for DNA extraction were aliquoted and stored at -80 °C for future analyses.

RESULTS: Overall, 517 Emirati men and women agreed to participate (68% response rate). Of the total participants, 495 (95.0%), 430 (82.2%), and 492 (94.4%), completed the questionnaire, physical measurements, and provided biological samples, respectively.

CONCLUSIONS: The pilot study demonstrated the feasibility of recruitment and completion of the study protocols for the first large-scale cohort study designed to identify emerging risk factors for the major non-communicable diseases in the region.

Original languageEnglish (US)
Number of pages1
JournalBMC Public Health
Volume18
Issue number1
DOIs
StatePublished - Jan 5 2018

Fingerprint

United Arab Emirates
Cohort Studies
Prospective Studies
Mouthwashes
Feasibility Studies
Hematology
Informed Consent
Cardiovascular Diseases
Obesity
Urine
DNA
Serum

Keywords

  • Adult
  • Chronic disease
  • Cohort studies
  • Pilot projects
  • Prospective studies
  • Public health
  • United Arab Emirates

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

The UAE healthy future study : a pilot for a prospective cohort study of 20,000 United Arab Emirates nationals. / Abdulle, Abdishakur; Alnaeemi, Abdullah; Aljunaibi, Abdullah; Al Ali, Abdulrahman; Al Saedi, Khaled; Al Zaabi, Eiman; Oumeziane, Naima; Al Bastaki, Marina; Al-Houqani, Mohammed; Al Maskari, Fatma; Al Dhaheri, Ayesha; Shah, Syed M.; Loney, Tom; El-Sadig, Mohamed; Oulhaj, Abderrahim; Wareth, Leila Abdel; Al Mahmeed, Wael; Alsafar, Habiba; Hirsch, Benjamin; Al Anouti, Fatme; Yaaqoub, Jamila; Inman, Claire K.; Al Hamiz, Aisha; Al Hosani, Ayesha; Haji, Muna; Alsharid, Teeb; Al Zaabi, Thekra; Al Maisary, Fatima; Galani, Divya; Sprosen, Tim; El Shahawy, Omar; Ahn, Jiyoung; Kirchhoff, Tomas; Ramasamy, Ravichandran; Schmidt, Ann Marie; Hayes, Richard; Sherman, Scott; Ali, Raghib.

In: BMC Public Health, Vol. 18, No. 1, 05.01.2018.

Research output: Contribution to journalArticle

Abdulle, A, Alnaeemi, A, Aljunaibi, A, Al Ali, A, Al Saedi, K, Al Zaabi, E, Oumeziane, N, Al Bastaki, M, Al-Houqani, M, Al Maskari, F, Al Dhaheri, A, Shah, SM, Loney, T, El-Sadig, M, Oulhaj, A, Wareth, LA, Al Mahmeed, W, Alsafar, H, Hirsch, B, Al Anouti, F, Yaaqoub, J, Inman, CK, Al Hamiz, A, Al Hosani, A, Haji, M, Alsharid, T, Al Zaabi, T, Al Maisary, F, Galani, D, Sprosen, T, El Shahawy, O, Ahn, J, Kirchhoff, T, Ramasamy, R, Schmidt, AM, Hayes, R, Sherman, S & Ali, R 2018, 'The UAE healthy future study: a pilot for a prospective cohort study of 20,000 United Arab Emirates nationals', BMC Public Health, vol. 18, no. 1. https://doi.org/10.1186/s12889-017-5012-2
Abdulle, Abdishakur ; Alnaeemi, Abdullah ; Aljunaibi, Abdullah ; Al Ali, Abdulrahman ; Al Saedi, Khaled ; Al Zaabi, Eiman ; Oumeziane, Naima ; Al Bastaki, Marina ; Al-Houqani, Mohammed ; Al Maskari, Fatma ; Al Dhaheri, Ayesha ; Shah, Syed M. ; Loney, Tom ; El-Sadig, Mohamed ; Oulhaj, Abderrahim ; Wareth, Leila Abdel ; Al Mahmeed, Wael ; Alsafar, Habiba ; Hirsch, Benjamin ; Al Anouti, Fatme ; Yaaqoub, Jamila ; Inman, Claire K. ; Al Hamiz, Aisha ; Al Hosani, Ayesha ; Haji, Muna ; Alsharid, Teeb ; Al Zaabi, Thekra ; Al Maisary, Fatima ; Galani, Divya ; Sprosen, Tim ; El Shahawy, Omar ; Ahn, Jiyoung ; Kirchhoff, Tomas ; Ramasamy, Ravichandran ; Schmidt, Ann Marie ; Hayes, Richard ; Sherman, Scott ; Ali, Raghib. / The UAE healthy future study : a pilot for a prospective cohort study of 20,000 United Arab Emirates nationals. In: BMC Public Health. 2018 ; Vol. 18, No. 1.
@article{b6f7df0c860f43b39b44d0b2751f340a,
title = "The UAE healthy future study: a pilot for a prospective cohort study of 20,000 United Arab Emirates nationals",
abstract = "BACKGROUND: The United Arab Emirates (UAE) is faced with a rapidly increasing burden of non-communicable diseases including obesity, diabetes, and cardiovascular disease. The UAE Healthy Future study is a prospective cohort designed to identify associations between risk factors and these diseases amongst Emiratis. The study will enroll 20,000 UAE nationals aged ≥18 years. Environmental and genetic risk factors will be characterized and participants will be followed for future disease events. As this was the first time a prospective cohort study was being planned in the UAE, a pilot study was conducted in 2015 with the primary aim of establishing the feasibility of conducting the study. Other objectives were to evaluate the implementation of the main study protocols, and to build adequate capacity to conduct advanced clinical laboratory analyses.METHODS: Seven hundred sixty nine UAE nationals aged ≥18 years were invited to participate voluntarily in the pilot study. Participants signed an informed consent, completed a detailed questionnaire, provided random blood, urine, and mouthwash samples and were assessed for a series of clinical measures. All specimens were transported to the New York University Abu Dhabi laboratories where samples were processed and analyzed for routine chemistry and hematology. Plasma, serum, and a small whole blood sample for DNA extraction were aliquoted and stored at -80 °C for future analyses.RESULTS: Overall, 517 Emirati men and women agreed to participate (68{\%} response rate). Of the total participants, 495 (95.0{\%}), 430 (82.2{\%}), and 492 (94.4{\%}), completed the questionnaire, physical measurements, and provided biological samples, respectively.CONCLUSIONS: The pilot study demonstrated the feasibility of recruitment and completion of the study protocols for the first large-scale cohort study designed to identify emerging risk factors for the major non-communicable diseases in the region.",
keywords = "Adult, Chronic disease, Cohort studies, Pilot projects, Prospective studies, Public health, United Arab Emirates",
author = "Abdishakur Abdulle and Abdullah Alnaeemi and Abdullah Aljunaibi and {Al Ali}, Abdulrahman and {Al Saedi}, Khaled and {Al Zaabi}, Eiman and Naima Oumeziane and {Al Bastaki}, Marina and Mohammed Al-Houqani and {Al Maskari}, Fatma and {Al Dhaheri}, Ayesha and Shah, {Syed M.} and Tom Loney and Mohamed El-Sadig and Abderrahim Oulhaj and Wareth, {Leila Abdel} and {Al Mahmeed}, Wael and Habiba Alsafar and Benjamin Hirsch and {Al Anouti}, Fatme and Jamila Yaaqoub and Inman, {Claire K.} and {Al Hamiz}, Aisha and {Al Hosani}, Ayesha and Muna Haji and Teeb Alsharid and {Al Zaabi}, Thekra and {Al Maisary}, Fatima and Divya Galani and Tim Sprosen and {El Shahawy}, Omar and Jiyoung Ahn and Tomas Kirchhoff and Ravichandran Ramasamy and Schmidt, {Ann Marie} and Richard Hayes and Scott Sherman and Raghib Ali",
year = "2018",
month = "1",
day = "5",
doi = "10.1186/s12889-017-5012-2",
language = "English (US)",
volume = "18",
journal = "BMC Public Health",
issn = "1471-2458",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The UAE healthy future study

T2 - a pilot for a prospective cohort study of 20,000 United Arab Emirates nationals

AU - Abdulle, Abdishakur

AU - Alnaeemi, Abdullah

AU - Aljunaibi, Abdullah

AU - Al Ali, Abdulrahman

AU - Al Saedi, Khaled

AU - Al Zaabi, Eiman

AU - Oumeziane, Naima

AU - Al Bastaki, Marina

AU - Al-Houqani, Mohammed

AU - Al Maskari, Fatma

AU - Al Dhaheri, Ayesha

AU - Shah, Syed M.

AU - Loney, Tom

AU - El-Sadig, Mohamed

AU - Oulhaj, Abderrahim

AU - Wareth, Leila Abdel

AU - Al Mahmeed, Wael

AU - Alsafar, Habiba

AU - Hirsch, Benjamin

AU - Al Anouti, Fatme

AU - Yaaqoub, Jamila

AU - Inman, Claire K.

AU - Al Hamiz, Aisha

AU - Al Hosani, Ayesha

AU - Haji, Muna

AU - Alsharid, Teeb

AU - Al Zaabi, Thekra

AU - Al Maisary, Fatima

AU - Galani, Divya

AU - Sprosen, Tim

AU - El Shahawy, Omar

AU - Ahn, Jiyoung

AU - Kirchhoff, Tomas

AU - Ramasamy, Ravichandran

AU - Schmidt, Ann Marie

AU - Hayes, Richard

AU - Sherman, Scott

AU - Ali, Raghib

PY - 2018/1/5

Y1 - 2018/1/5

N2 - BACKGROUND: The United Arab Emirates (UAE) is faced with a rapidly increasing burden of non-communicable diseases including obesity, diabetes, and cardiovascular disease. The UAE Healthy Future study is a prospective cohort designed to identify associations between risk factors and these diseases amongst Emiratis. The study will enroll 20,000 UAE nationals aged ≥18 years. Environmental and genetic risk factors will be characterized and participants will be followed for future disease events. As this was the first time a prospective cohort study was being planned in the UAE, a pilot study was conducted in 2015 with the primary aim of establishing the feasibility of conducting the study. Other objectives were to evaluate the implementation of the main study protocols, and to build adequate capacity to conduct advanced clinical laboratory analyses.METHODS: Seven hundred sixty nine UAE nationals aged ≥18 years were invited to participate voluntarily in the pilot study. Participants signed an informed consent, completed a detailed questionnaire, provided random blood, urine, and mouthwash samples and were assessed for a series of clinical measures. All specimens were transported to the New York University Abu Dhabi laboratories where samples were processed and analyzed for routine chemistry and hematology. Plasma, serum, and a small whole blood sample for DNA extraction were aliquoted and stored at -80 °C for future analyses.RESULTS: Overall, 517 Emirati men and women agreed to participate (68% response rate). Of the total participants, 495 (95.0%), 430 (82.2%), and 492 (94.4%), completed the questionnaire, physical measurements, and provided biological samples, respectively.CONCLUSIONS: The pilot study demonstrated the feasibility of recruitment and completion of the study protocols for the first large-scale cohort study designed to identify emerging risk factors for the major non-communicable diseases in the region.

AB - BACKGROUND: The United Arab Emirates (UAE) is faced with a rapidly increasing burden of non-communicable diseases including obesity, diabetes, and cardiovascular disease. The UAE Healthy Future study is a prospective cohort designed to identify associations between risk factors and these diseases amongst Emiratis. The study will enroll 20,000 UAE nationals aged ≥18 years. Environmental and genetic risk factors will be characterized and participants will be followed for future disease events. As this was the first time a prospective cohort study was being planned in the UAE, a pilot study was conducted in 2015 with the primary aim of establishing the feasibility of conducting the study. Other objectives were to evaluate the implementation of the main study protocols, and to build adequate capacity to conduct advanced clinical laboratory analyses.METHODS: Seven hundred sixty nine UAE nationals aged ≥18 years were invited to participate voluntarily in the pilot study. Participants signed an informed consent, completed a detailed questionnaire, provided random blood, urine, and mouthwash samples and were assessed for a series of clinical measures. All specimens were transported to the New York University Abu Dhabi laboratories where samples were processed and analyzed for routine chemistry and hematology. Plasma, serum, and a small whole blood sample for DNA extraction were aliquoted and stored at -80 °C for future analyses.RESULTS: Overall, 517 Emirati men and women agreed to participate (68% response rate). Of the total participants, 495 (95.0%), 430 (82.2%), and 492 (94.4%), completed the questionnaire, physical measurements, and provided biological samples, respectively.CONCLUSIONS: The pilot study demonstrated the feasibility of recruitment and completion of the study protocols for the first large-scale cohort study designed to identify emerging risk factors for the major non-communicable diseases in the region.

KW - Adult

KW - Chronic disease

KW - Cohort studies

KW - Pilot projects

KW - Prospective studies

KW - Public health

KW - United Arab Emirates

UR - http://www.scopus.com/inward/record.url?scp=85047368478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047368478&partnerID=8YFLogxK

U2 - 10.1186/s12889-017-5012-2

DO - 10.1186/s12889-017-5012-2

M3 - Article

VL - 18

JO - BMC Public Health

JF - BMC Public Health

SN - 1471-2458

IS - 1

ER -